Physician profile
Brian D Busconi
NPI 1245214493
$684,393.58
in general payments reported to CMS, 2019-2025
25 companies · $90K in 2025
The $90K reported for 2025 was more than what 97% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109K · 2020: $75K · 2021: $74K · 2022: $99K · 2023: $121K · 2024: $115K · 2025: $90K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $176K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $78K · Royalty Or License: $52K · Travel and Lodging: $12K · Food and Beverage: $5,616 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $176,351.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $77,719.12 |
| Royalty Or License | $51,923.94 |
| Travel and Lodging | $11,944.11 |
| Food and Beverage | $5,615.90 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $240,546.89 | 2019-2025 | Milagro, Rigidloop, Omnispan Orthocord |
| Arthrex, INC. | $209,657.14 | 2019-2025 | |
| Depuy Synthes Products, INC. | $164,593.88 | 2019-2025 | Mitek Cruciate+, Omnispan Orthocord, Rigidloop |
| Linvatec Corporation | $31,707.82 | 2022-2024 | Biobrace 23mm, Linvatec Shoulder Arthroscopy |
| Pacira Pharmaceuticals Incorporated | $18,373.73 | 2023-2025 | Exparel, Iovera, Zilretta |
| Kairos Surgical INC | $7,161.97 | 2019-2025 | |
| Prodigy Surgical Distribution, INC. | $3,837.79 | 2020-2025 | |
| Pacira Therapeutics, INC. | $2,885.60 | 2019-2021 | |
| Biorez, INC. | $2,000.00 | 2022 | |
| Depuy Synthes Sales INC. | $1,076.54 | 2019-2025 | Dynacord, Healix Knotless Peek, Vapr |
| Ferring Pharmaceuticals INC. | $538.26 | 2019-2025 | Euflexxa |
| Anika Therapeutics, INC. | $287.80 | 2020-2024 | Integrity |
| Smith+Nephew, INC. | $256.95 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $208.67 | 2020-2023 | Accufill, Tapestry |
| Electronic Waveform Lab, INC. | $208.13 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Miach Orthopaedics, INC. | $184.34 | 2025 | |
| Bioventus LLC | $162.37 | 2019-2025 | Durolane |
| Stryker Corporation | $160.00 | 2023 | Insignia, Motionsense Digital Goniometer, Mako |
| Orthofix Medical, INC. | $154.86 | 2019-2025 | Physio-Stim |
| Si-Bone, INC. | $153.29 | 2023 | |
| Pinnacle, INC | $103.79 | 2019 | |
| Ossdsign USA Incorporated | $44.48 | 2025 | Ossdsign Catalyst |
| Vertex Pharmaceuticals Incorporated | $35.49 | 2025 | |
| Acumed LLC | $30.37 | 2019 | |
| Baudax Bio INC. | $23.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Busconi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.